Recent Finacing
Recent Raise
Pronota, based in Ghent, uses its MASStermind platform to discover, biologically characterize and develop immunoassays for heart-failure protein biomarkers for clinical validation and regulatory submission.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor